Cite
Jay C, Nemunaitis G, Nemunaitis J, et al. Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2). Gene Regul Syst Bio. 2008;2:243-52doi: 10.4137/grsb.s728.
Jay, C., Nemunaitis, G., Nemunaitis, J., Senzer, N., Hinderlich, S., Darvish, D., Ogden, J., Eager, J., Tong, A., & Maples, P. B. (2008). Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2). Gene regulation and systems biology, 2243-52. https://doi.org/10.4137/grsb.s728
Jay, Chris, et al. "Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)." Gene regulation and systems biology vol. 2 (2008): 243-52. doi: https://doi.org/10.4137/grsb.s728
Jay C, Nemunaitis G, Nemunaitis J, Senzer N, Hinderlich S, Darvish D, Ogden J, Eager J, Tong A, Maples PB. Preclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2). Gene Regul Syst Bio. 2008 Jun 20;2:243-52. doi: 10.4137/grsb.s728. PMID: 19787087; PMCID: PMC2733101.
Copy
Download .nbib